-
-
-
-
-
-
-
IntelGenx Announces FDA’s Acceptance of Resubmitted RIZAPORT® New Drug Application
-
-
-
-
-
-
-
IntelGenx and RedHill Biopharma (RDHL) Enter Exclusive License Agreement with Pharmatronic Co. for RIZAPORT in South Korea
-
-
-
-
-
-
-
RedHill Biopharma and IntelGenx Announce RIZAPORT™ Commercialization Term Sheet with Grupo JUSTE for Spain and Additional Potential Territories
15,434 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

